MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202611102269 A) filed by Dr. Arun Kumar Mishra; Dr. R. Karthikha; Dr. L. Nagarajan; Mmc Priyadharsini; P Kumari Deepika; and Dr. A. Jenif Dsouza on August 24, 2026, for Ai-Guided Breath Biomarker Analysis Device For Multi-Disease Screening Via Volatile Organic Compound Mapping.
Inventors include Dr. Arun Kumar Mishra; Dr. R. Karthikha; Dr. L. Nagarajan; Mmc Priyadharsini; P Kumari Deepika; and Dr. A. Jenif Dsouza.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: The present invention discloses an AI-guided breath biomarker analysis device for multi-disease screening via volatile organic compound mapping. The device provides a non-invasive platform for analyzing volatile organic compounds present in exhaled human breath. The system comprises a breath sampling module, breath conditioning chamber, VOC sensor array, signal conditioning and data acquisition module, processing controller, artificial intelligence analysis module, biomarker database, and display or communication interface. The VOC sensor array detects multidimensional chemical response patterns from the collected breath sample. The acquired signals are processed using noise filtering, normalization, baseline correction, environmental compensation, and feature extraction techniques to generate a representative VOC biomarker fingerprint. An artificial intelligence model analyzes the fingerprint and maps it against disease-associated reference profiles stored in a biomarker database. The system generates one or more disease probabilities, risk scores, confidence values, or screening classifications corresponding to multiple target disease conditions. The device enables rapid, automated, and non-invasive preliminary screening while reducing dependence on invasive sample collection and laboratory-based analysis. The system is suitable for point-of-care and decentralized screening applications and provides AI-assisted decision support for identifying individuals who may require further clinical evaluation.
Disclaimer: Curated by HT Syndication.
